Further, it was found that TME of CRC induced a dramatic downregulation of IFNAR1 on CD8+ TILs and transferred CAR-T cells, leading to impaired survival of these cells and dampened anti-tumor responses of CAR-T and anti-PD-1 [86]. The gene discussed is CD8A; the disease is neoplasm.